This invention provides vaccines comprising two or more recombinant HerpesSimplex Virus (HSV) proteins selected from a gD protein, a gC protein and a gE protein;and methods of vaccinating a subject against HSV and treating, impeding, inhibiting,reducing the incidence of, or suppressing an HSV infection or a symptom or manifestationthereof, comprising administration of a vaccine of the present invention.